Company / Book Value per Share
Monte Rosa Therapeutics, Inc. Book Value per Share History
FY2020-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Book Value per Share
$3.016
FY2024
5-year range
-$32.123 / $13.901
FY2020-FY2024
Trend
-13.5%
vs FY2023
Sector context
#133 of 209
Health Care
What the data says
At $3.016, Monte Rosa Therapeutics, Inc.'s book value per share ranks #133 of 209 in the Health Care sector. Book Value per Share has declined for 3 consecutive years, from $13.901 in FY2021 to $3.016 in FY2024.
Based on SEC 10-K filings.
$3.016 in FY2024 with a 3-year CAGR of -39.9%.
Declined from $5.747 to $3.016 over the past 2 years.
Health Care sector context is included.
Book Value per Share over time
Growth rates
- 3-Year CAGR
- -39.9%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#133 of 209 in Health CareTop 64% of 209This company $3.016 Sector average $189.406
▼
-98.4% below sector average
Key checks
Key Insights
- Monte Rosa Therapeutics, Inc.'s book value per share has declined for 3 consecutive years.
- 3-year CAGR of -39.9%, indicating a declining trend.
- In FY2024, book value per share decreased 13.5% year-over-year.
- Ranks #133 out of 209 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 0.22 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $3.016 | -13.5% |
| FY2023 | $3.488 | -39.3% |
| FY2022 | $5.747 | -58.7% |
| FY2021 | $13.901 | +143.3% |
| FY2020 | -$32.123 | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026